M&T Bank
MRVI icon

M&T Bank’s Maravai LifeSciences MRVI Stock Holding History

M&T Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.8K Sell
13,358
-449
-3% -$1.52K ﹤0.01% 1674
2025
Q4 		$45.2K Buy
+13,807
New +$46.5K ﹤0.01% 1657
2024
Q4 		– Sell
-21,757
Closed -$181K – 1674
2024
Q3 		$181K Sell
21,757
-6,011
-22% -$52K ﹤0.01% 1533
2024
Q2 		$200K Buy
27,768
+2,251
+9% +$19.4K ﹤0.01% 1474
2024
Q1 		$221K Buy
25,517
+5,410
+27% +$36.6K ﹤0.01% 1455
2023
Q4 		$131K Buy
20,107
+2,972
+17% +$19.2K ﹤0.01% 1544
2023
Q3 		$172K Buy
17,135
+3,158
+23% +$34.7K ﹤0.01% 1457
2023
Q2 		$173K Buy
13,977
+2,185
+19% +$29.5K ﹤0.01% 1497
2023
Q1 		$165K Buy
+11,792
New +$169K ﹤0.01% 1510

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

M&T Bank's MRVI Position: Q1 2026 in Review

M&T Bank reduced its Maravai LifeSciences (MRVI) stake by 3.3% in Q1 2026, selling an estimated $1.52K and leaving 13,358 shares worth $37.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

M&T Bank first reported a position in MRVI in Q1 2023 and has held it in 9 quarters since. The position peaked at $221K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • M&T Bank held 13,358 shares of Maravai LifeSciences worth $37.8K as of Q1 2026.
  • M&T Bank sold 449 Maravai LifeSciences shares in Q1 2026, an estimated $1.52K.
  • Maravai LifeSciences made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1674 holding.
  • M&T Bank first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 9 quarters since.
  • M&T Bank's Maravai LifeSciences position peaked at $221K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.